Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Exchange Rate Effect (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Exchange Rate Effect for 16 consecutive years, with $7661.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 375.28% year-over-year to $7661.0, compared with a TTM value of $44494.0 through Oct 2025, up 352.38%, and an annual FY2025 reading of $44494.0, up 352.38% over the prior year.
  • Exchange Rate Effect was $7661.0 for Q4 2025 at Pharma-Bio Serv, up from $4377.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $90619.0 in Q1 2023 and bottomed at -$58225.0 in Q4 2023.
  • Average Exchange Rate Effect over 5 years is $1384.8, with a median of -$2641.5 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect crashed 568.95% in 2022, then soared 1509.75% in 2023.
  • Year by year, Exchange Rate Effect stood at -$32169.0 in 2021, then soared by 32.62% to -$21675.0 in 2022, then crashed by 168.63% to -$58225.0 in 2023, then skyrocketed by 95.22% to -$2783.0 in 2024, then soared by 375.28% to $7661.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for PBSV at $7661.0 in Q4 2025, $4377.0 in Q3 2025, and $51541.0 in Q2 2025.